Skip to main content
. 2020 Oct 21;25:100329. doi: 10.1016/j.jbo.2020.100329

Fig. 3.

Fig. 3

Comparing serum vitamin D [25(OH)D] levels of patients with primary malignant bone tumours [mean 16.56 ng/ml (41.4 nmol/L); n = 51] to patients with bone metastases [mean 23.9 ng/ml (59.75 nmol/L); n = 31] revealed significant differences between groups (p = 0.008).